Shelter Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2025 ,inter alia, to consider and approve 1. To consider, approve and ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shelter Pharma has informed BSE that its Board of Directors will meet on Monday, 10 November 2025 at its registered office in Ahmedabad. The main item on the agenda is to consider and approve the Unaudited Financial Results for the half year ended 30 September 2025, under Regulation 33 of the SEBI LODR Regulations. Alongside this, the Board may take up any other business permitted by the Chair. The company's trading window for insiders has already been closed since 1 October 2025 and will reopen 48 hours after the results are declared.
This is a routine pre-results intimation and carries no direct impact on the stock price. Investors should watch the H1 FY26 results announcement on or after 10 November 2025 for actual financial performance, which will be the next key catalyst.